R&D Why clinical trials lose a quarter of their patients before ... Data fragmentation creates unnecessary burden on sponsors and the people clinical trials aim to serve.
R&D Trial complexity is the new normal When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.
Digital AI in clinical trials: Building better trials before they st... With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.
Digital Sponsored Technology solutions for smarter clinical trials: Inventus In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos
R&D Navigating the new ICH E6 (R3): Key changes for sponsors These new regulations for running clinical trials in the UK will be a legal requirement from 28th April 2026.
Patients Tips to strengthen clinical trials by improving the patient ... From consumer products to clinical trials, anything that is designed without input from its intended recipients will likely feel disconnected from their needs.
News Sanofi eyeing pipeline deals ahead of Dupixent patent loss Sanofi's CEO says adding to the group's pipeline through M&A and licensing will be "critical" as it prepares for generic competition to Dupixent.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
